Mark C. Twyman
Corporate Officer/Principal chez INOVIO PHARMACEUTICALS, INC.
Postes actifs de Mark C. Twyman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15/11/2018 | - |
Historique de carrière de Mark C. Twyman
Anciens postes connus de Mark C. Twyman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NOVAVAX, INC. | Sales & Marketing | 22/12/2015 | 01/11/2016 |
| GI DYNAMICS, INC. | Corporate Officer/Principal | 01/11/2011 | 01/07/2014 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2008 | 01/01/2011 |
| Medimmune, Inc. | Corporate Officer/Principal | 01/01/2006 | 01/01/2011 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2006 | 01/01/2008 |
| MERCK & CO., INC. | Sales & Marketing | 01/01/1988 | 01/01/2006 |
| LENSAR, INC. | Sales & Marketing | - | - |
Formation de Mark C. Twyman
| Dickinson College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 11 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Sales & Marketing | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 9 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| LENSAR, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
GI Dynamics, Inc.
 GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Bourse
- Insiders
- Mark C. Twyman
- Expérience
